Put some extra omega 3 fatty acids in your diet today and celebrate March 3 as Omega- 3 Awareness Day.

Foods rich in omega-3 fats, especially those in fish and seafood, may reduce your risk of getting colon cancer. Read the rest of this entry »

While colonoscopy is effective in preventing cancers and advanced polyps in the lower part of the colon and rectum, it is less successful in stopping them in the right side or upper colon.

Looking back at almost 3,300 colonoscopies performed in community gastroenterology practices in Germany, researchers found a substantial reduction in large polyps or cancers in the left side of the colon and rectum among patients who had had a colonoscopy in the past ten years compared to those who hadn’t had one.

However, in the upper part of the colon, risk for an advanced polyp or cancer was the same whether or not the patient had a previous colonoscopy.

Overall, colonoscopy reduced the risk of a cancer or an advanced adenoma by 50 percent.

Read the rest of this entry »

Carolyn "Bo" Aldige

C3 congratulates the Prevent Cancer Foundation on their 25th anniversary this month.

We are proud of the work they do, especially in encouraging screening to prevent colorectal cancer.  This March they will sponsor the 12th Dialogue for Action Prevention Hits the Headlines.

Prevent Cancer also sponsors the Super Colon Tour, an educational program accompanied by a large crawl-through colon.  2010 tour appearances are being scheduled now. Read the rest of this entry »

ECCO/ESMO UPDATE — BERLIN 2009

Being overweight was a key reason for at least 124,000 new cancers in European countries in 2008, including nearly 24,000 from colorectal cancer.

3.2 percent of new cancer diagnoses in men and 8.8 percent of women’s cancers could be attributed to excessive body mass index (BMI).  This was a dramatic increase from  2002 that found 70,000 cases of cancer directly related to obesity out of 2.2 million European cancers overall. Read the rest of this entry »

ECCO/ESMO UPDATE — BERLIN 2009

Although initial reports found no reduction in polyps or cancer in people with Lynch syndrome who took aspirin and/or resistant starch supplements, longer follow-up tells a difference story.

About five years after trial participants began taking aspirin or a placebo, differences began to emerge. Even though patients in the trial only took aspirin for four years, later followup found significantly fewer colon colon cancers among those who had used  aspirin, as well as fewer Lynch-related cancers overall.   There were almost three times as many colon cancers in Lynch carriers who took a placebo compared to those who used aspirin. Read the rest of this entry »